Future trends in drugs for migraine prophylaxis

Neurological Sciences

Volumn 33, Issue SUPPL. 1, 2012, Pages

  Barbanti, Piero ^a   Aurilia, Cinzia ^a   Egeo, Gabriella ^a   Fofi, Luisa ^a  

^a IRCCS SAN RAFFAELE PISANA   (Italy)

Author keywords

Disability; Migraine; Prophylaxis; Treatment

Indexed keywords

ADX 10059; AMITRIPTYLINE; ANTICONVULSIVE AGENT; ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BOTULINUM TOXIN A; CALCIUM ANTAGONIST; CARISBAMATE; COLECALCIFEROL; FLUNARIZINE; HARKOSERIDE; INDUCIBLE NITRIC OXIDE SYNTHASE; MELATONIN; METABOTROPIC RECEPTOR ANTAGONIST; METHYSERGIDE; METOPROLOL; MILNACIPRAN; PERAMPANEL; PLACEBO; PROPRANOLOL; RAMELTEON; S [2 (1 IMINOETHYLAMINO)ETHYL]HOMOCYSTEINE; SEROTONIN ANTAGONIST; SIMVASTATIN; TIMOLOL; TONABERSAT; TOPIRAMATE; UNCLASSIFIED DRUG; UNINDEXED DRUG; VALPROIC ACID;

ANOREXIA; BIRTH DEFECT; BRADYCARDIA; CONFERENCE PAPER; DIZZINESS; DRUG MECHANISM; EPISODIC MIGRAINE; FATIGUE; HAIR LOSS; HEART MUSCLE FIBROSIS; HUMAN; HYPOTENSION; LUNG FIBROSIS; MEMORY DISORDER; MIGRAINE; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; NAUSEA; NONHUMAN; PARESTHESIA; PHASE 2 CLINICAL TRIAL (TOPIC); RANDOMIZED CONTROLLED TRIAL (TOPIC); RETROPERITONEAL FIBROSIS; SIDE EFFECT; SOMNOLENCE; SPREADING CORTICAL DEPRESSION; TASTE DISORDER; TRANSFORMED MIGRAINE; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

ANALGESICS; ANTICONVULSANTS; BOTULINUM TOXINS, TYPE A; CLINICAL TRIALS AS TOPIC; FORECASTING; HUMANS; MIGRAINE DISORDERS; PLANT PREPARATIONS;

EID: 84864260142     PISSN: 15901874     EISSN: 15903478     Source Type: Journal    
DOI: 10.1007/s10072-012-1058-1     Document Type: Conference Paper

References (29)

1. Lipton RB, Bigal ME, Diamond M et al (2007) Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 68:343-349 (Pubitemid 46184209)
2. Sprenger T, Goadsby P (2009) Migraine pathogenesis and state of pharmacological treatment options. BMC Med 16(7):71
3. Vikelis M, Rapoport AM (2010) Role of antiepileptic drugs as preventive agents for migraine. CNS Drugs 24:21-33
4. Galletti F, Cupini LM, Corbelli I et al (2009) Pathophysiological basis of migraine prophylaxis. Prog Neurobiol 89:176-192
5. Wyszynski DF, Nambisan M, Surve T et al (2005) Increased rate of major malformations in offspring exposed to valproate during pregnancy. Neurology 22(64):961-965 (Pubitemid 40388443)
6. Linde K, Rossnagel K (2004) Propranolol for migraine prophylaxis. Cochrane Database Syst Rev 2:CD003225
7. Jackson JL, Shimeall W, Sessums L et al (2010) Tricyclic antidepressants and headaches: systematic review and meta-analysis. BMJ 20(341):c5222. doi:10.1136/bmj.c5222
8. Reveiz-Herault L, Cardona AF, Ospina EG et al (2003) Effectiveness of flunarizine in the prophylaxis of migraine: a meta-analytical review of the literature. Rev Neurol 16-31(36):907-912 (Pubitemid 36741395)
9. Silberstein SD (1998) Methysergide. Cephalalgia 18:421-435 (Pubitemid 28459458)
10. Osterman PO (1977) A comparison between placebo, pizotifen and 1-isopropyl-3-hydroxy-5-semicarbazono-6-oxo-2.3.5.6-tetrahydroindol (Divascan) in migraine prophylaxis. Acta Neurol Scand 56:17-28 (Pubitemid 8116007)
11. Diener HC, Gendolla A, Feuersenger A et al (2009) Telmisartan in migraine prophylaxis: a randomized, placebo-controlled trial. Cephalalgia 29:921-927
12. Tronvik E, Stovner LJ, Helde G et al (2003) Prophylactic treatment of migraine with an angiotensin II receptor blocker: a randomized controlled trial. JAMA 1(289):65-69 (Pubitemid 36026279)
13. Schuh-hofer S, Flach U, Meisel A et al (2007) Efficacy of lisinopril in migraine prophylaxis-an open label study. Eur J Neurol 14:701-703 (Pubitemid 46849050)
14. Schoenen J, Jacquy J, Lenaerts M (1998) Effectiveness of highdose riboflavin in migraine prophylaxis: a randomized controlled trial. Neurology 50:466-470
15. Sándor P, Di Clemente L, Coppola G et al (2005) Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized, controlled trial. Neurology 64:713-715 (Pubitemid 40261904)
16. Peikert A, Wilimzig C, Kohne-Volland R (1996) Prophylaxis of migraine with oral magnesium: results from a prospective, multicentre, placebo-controlled and double blind randomized study. Cephalalgia 16:257-263 (Pubitemid 26189252)
17. Diener HC, Rahlfs VW, Danesch U (2004) The first placebocontrolled trial of a special butterbur root extract for the prevention of migraine: reanalysis of efficacy criteria. Eur Neurol 51:89-97 (Pubitemid 38339722)
18. Pittler MH, Ernst E (2004) Feverfew for preventing migraine. Cochrane Database Syst Rev 1:CD002286
19. Shuhendler AJ, Lee S, Siu M et al (2009) Efficacy of botulinum toxin type A for the prophylaxis of episodic migraine headaches: a meta-analysis of randomized, double-blind, placebo-controlled trials. Pharmacotherapy 29:784-789
20. Aurora SK, Dodick DW, Turkel CC et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 1 trial. Cephalalgia 30:793-803
21. Diener HC, Dodick DW, Aurora SK et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: results from the double-blind, randomized, placebo-controlled phase of the PREEMPT 2 trial. Cephalalgia 30:804-814
22. Dodick DW, Turkel CC, DeGryse RE et al (2010) OnabotulinumtoxinA for treatment of chronic migraine: pooled results from the double-blind, randomized, placebo-controlled phases of the PREEMPT clinical program. Headache. 50:921-936
23. Hauge AW, Asghar MS, Schytz HW et al (2009) Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study. Lancet Neurol 8:718-723
24. Marin JC, Goadsby PJ (2010) Glutamatergic fine tuning with ADX-10059: a novel therapeutic approach for migraine? Expert Opin Investig Drugs 19:555-561
25. Høivik HO, Laurijssens BE, Harnisch LO et al (2010) Lack of efficacy of the selective iNOS inhibitor GW274150 in prophylaxis of migraine headache. Cephalalgia 30:1458-1467 [Epub 2010 May 12]
26. Peres MF, Masruha MR, Zukerman E et al (2006) Potential therapeutic use of melatonin in migraine and other headache disorders. Expert Opin Investig Drugs 15:367-375
27. Cady RK, Mathew N, Diener HC et al (2009) Evaluation of carisbamate for the treatment of migraine in a randomized, double-blind trial. Headache 49:216-226
28. Barbanti P, Fabbrini G, Pesare M et al (2002) Unilateral cranial autonomic symptoms in migraine. Cephalalgia 22:256-259 (Pubitemid 41701441)
29. Schulman EA, Peterlin BL, Lake AE 3rd et al (2009) Defining refractory migraine: results of the RHSIS Survey of American Headache Society members. Headache 49:509-518. [Epub 2009 Feb 25]